Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Customization for Optimal Oxygen Supply

New micro solenoid valves supplement Aventics components for oxygen concentratorsThe recently presented MSV8/MSV12 valve series provide new options in equipment design: With customer-specific valves, Aventics supports the trend towards ever smaller, ever lighter, and ever more precise oxygen concentrators. Laatzen/Düsseldorf, Germany, November 10, 2017 – “Form follows function – this design principle is now more important for pneumatics in medical engineering than ever before,” says Paul Gant, Director Global Life Sciences at Aventics. “We make it possible to construct medical equipment

Collector Nomination Committee 2018 AGM appointed

Gothenburg, Sweden – Collector AB (publ) (Nasdaq Stockholm: COLL). Collector AB (publ):s Annual General Meeting will be held in Gothenburg, Sweden on Tuesday 24 April 2018. In accordance with a resolution at Collectors AGM held on 25 April 2017, it is hereby announced that the company’s major owners have between themselves appointed a Nomination Committee.·  Erik Selin, for Fastighets AB Balder ·  Rolf Lundström, for StrategiQ Capital AB ·  Fabian Hielte for Ernström Kapitalpartner Finans AB ·  Lena Apler, Chairman of the Board Collector AB (publ) Chairman of the Nomination

From Oxygen Concentrators to Industrial Automation

Aventics produces pneumatic components for all tasks in medical engineeringWith high production standards, worldwide support, and customer-specific components, Aventics has positioned itself as the ideal partner for the life sciences industry. The pneumatics specialist offers integrated solutions for current challenges, such as increasing mobility of medical equipment and networked applications. Laatzen/Düsseldorf, Germany, November 10, 2017 – Aventics products can be found in all areas of medical engineering: They prepare and distribute air and oxygen as well as medical gases in

Shoreditch Making Strides in War on Food Waste

Innovative new app is tackling food waste in ShoreditchIf food waste was a country, it would be the third largest emitter of greenhouse gases after the US and China. This shocking statistic should be enough for anyone to realise that food waste is a problem we need to act on, and it is something anyone can play a part in. Tackling food waste is especially important in London, where it costs the average person £200 a year. As well as this, for every 5 bags of shopping bought, one is thrown away with food that could have been used to feed hungry mouths. Reducing food waste has benefits

Viking Line Abp: Revised earnings forecast for the 2017 financial year

Viking Line Abp            INSIDE INFORMATION            10.11.2017, 2.05 PMRevised earnings forecast for the 2017 financial yearCompetition in Viking Line's service area entails continued pressure on prices and volumes, which will have an adverse effect on net sales revenue per passenger. Bunker prices are still expected to be higher than in 2016. The expected revision in Finland's restitution law for 2017 has been delayed, and it is uncertain whether this can be carried out so that it will affect consolidated earnings for 2017. Overall, the Board of Director’s assessment is that

Asetek Provides Progress Update on Undisclosed Data Center Customer

November 7, 2017 – Asetek (ASETEK.OL): Reference is made to stock exchange release issued on 22 February 2017, in which Asetek announced the signing of a product development agreement with an anonymous major player in the data center space. The customer has informed Asetek it now targets product launch in March 2018, instead of as originally planned at the SC17 trade show next week, due to factors outside of Asetek’s control. “We have collaborated with this customer for several years towards a market launch of our solutions. Unfortunately, postponements are not uncommon in our

Notice of extraordinary general meeting in Cantargia AB (publ)

The shareholders of Cantargia AB (publ) are summoned to an extraordinary general meeting on Monday 27 November 2017 at 15.00 CET at Medicon Village, Scheelevägen 2 (conference room Venus, house 301), Lund, Sweden.Participation and notice   Shareholders who wish to participate in the meeting must: • be registered in the share register maintained by Euroclear Sweden AB on Tuesday 21 November 2017, and • give notice of participation to the company no later than Tuesday 21 November 2017. The notice shall be made by regular mail to Cantargia AB (publ), Medicon Village, Scheelevägen 2,

Management changes in Securitas European division

Magnus Ahlqvist, new President and CEO of Securitas AB as of March 2018, will during 2018 keep the position as Divisional President of Security Services Europe. Henrik Zetterberg has been appointed COO for the division with focus on Northern Europe. Aimé Lyagre continues as COO and CTO with expanded responsibilities for countries in Western Europe.As communicated on August 13, 2017, Magnus Ahlqvist has been appointed new President and CEO of Securitas AB, replacing Alf Göransson. Magnus Ahlqvist will take up his new position in March 2018. During 2018, Magnus Ahlqvist will keep his current

BENRALIZUMAB POSITIVE CHMP IN EOSINOPHILIC ASTHMA

This announcement contains inside information 10 November 2017 11:35 GMT BENRALIZUMAB RECEIVES POSITIVE EU CHMP OPINION FOR SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA  Benralizumab uniquely targets and rapidly depletes eosinophils and is the first respiratory biologic with an 8-week maintenance dosing schedule  Recommendation based on extensive Phase III programme demonstrating significant reductions in exacerbations, improvements in lung function and reductions in oral steroid use, respectively AstraZeneca and its global biologics research and development arm, MedImmune, today

#17-1061 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from November 13, 2017, 8 Mini futures issued by Vontobel Financial Products GmbH will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB. Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from November 13, 2017 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AGUnderlying: Vestas Wind Systems A/S Gold (troy ounce) ICE Brent Crude Oil Futures OMXS30 index Current values

Interim Report January-September 2017

January-September 2017 compared with January-September 2016: · Operating profit for the Länsförsäkringar Alliance’s non-life insurance operations increased to SEK 6,193 M (3,645). Premiums earned after ceded reinsurance rose to SEK 18,942 M (17,933). · The technical result for the Länsförsäkringar Alliance’s non-life insurance operations increased to SEK 1,447 M (1,177). The combined ratio improved to 94% (96). · Investment income for the Länsförsäkringar Alliance increased to SEK 5,213 M (3,405). · Operating profit for the Bank Group increased to SEK 1,166 M (1,077). Net

Interim Report January-September 2017

”Länsförsäkringar Bank is continuing to perform strongly and we can report our best ever quarterly results. It is tremendously gratifying that we are once again the single player on the bank market with the most satisfied retail customers and, for the first time, we also have the most satisfied corporate customers according to the Swedish Quality Index’s most recent survey that was published in the beginning of October (SKI 2017). The key to our success is the excellent work carried out locally at the regional insurance companies and that results in high customer satisfaction. The healthy

Interim Report January-September 2017

”Länsförsäkringar Hypotek’s retail mortgage operations are continuing to perform strongly and we see an increase in the number of customers and higher market shares. We delivered a strong operating profit for the period and are further strengthening our market position. The strong local presence of the regional insurance companies and high customer satisfaction are the keys to the stable growth in lending. We are continuing to maintain our high credit quality and loan losses for the period remained unchanged at very low levels. The trend in housing prices remains a much debated issue and it

Interim Report January-September 2017

January-September 2017 compared with January-September 2016: · The Group’s operating profit increased to SEK 2,201 M (1,743), including a positive non-recurring item of SEK 260 M in the first quarter. The return on equity amounted to 11% (10). · Operating profit for the non-life insurance operations increased to SEK 781 M (461), of which SEK 260 M comprised remuneration for the transferred accident and health insurance business to the regional insurance companies. Premiums earned after ceded reinsurance rose to SEK 4,196 M (3,989). The combined ratio amounted to 92% (92). ·

ADDvise signs agreement to acquire AB Germa

•    ADDvise Group AB (publ) has entered into an agreement with Ferno Norden AS and Ferno LLC to acquire all shares in Aktiebolaget Germa with admission planned on December 1st, 2017.•    The purchase price amounts to SEK 17 million. The Acquisition is based on a cash and debt free basis to be paid in cash.•    Germa’s production facility with a market value of SEK 4.5 million is included in the purchase.•    The fiscal year 2016, Germa had a turnover of SEK 30.1 million and generated an EBITDA of SEK 3.4 million. Motives for the acquisition Germa is a profitable product company

Prospectus for Arjo AB (publ) published

Getinge’s wholly-owned subsidiary Arjo AB (publ) has prepared a prospectus regarding the admission to trading of the company’s shares of series B. The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority. Similar to Getinge’s shares of series A, Arjo’s shares of series A will not be listed.The prospectus can be obtained from Getinge and SEB and is available at Getinge’s website, www.getinge.com and at SEB’s website for prospectuses, www.sebgroup.com/prospectuses. For more information: Lars Mattsson, GetingeHead of Investor Relations

Telia Company intends to buy back outstanding bonds

Not for distribution in or into or to any person located or resident in the United States, its territories and possessions (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern Mariana Islands), any state of the United States or the District of  Columbia or in or into any other jurisdiction where it is unlawful to distribute this announcement.Telia Company AB (the “Issuer”) today announces an invitation to holders of its outstanding EUR 500,000,000 1.375 percent, Notes due February 18, 2019, EUR 750,000,000 4.25 percent, Notes due February 18,

SAS traffic figures - October 2017

• Scheduled traffic (RPK) decreased 3% and the capacity (ASK) was up 2%. • The load factor decreased by 3.8 p.u. versus last year to 74.9%. • Scheduled number of passengers amounted to 2.6 million in October. • The preliminary currency adjusted yield and PASK increased 9% and 4% respectively in October 2017 vs. last year. The nominal yield and PASK increased 7% and 2% respectively in October 2017 vs. last year.Market development and capacity outlook After a robust development of the seasonal demand during the summer, demand has shifted back to more business purpose traveling. In

BerGenBio ASA: Invitation to Third Quarter 2017 Results Presentation and Webcast

Bergen, Norway, 10 November 2017 – BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, will announce its results for the third quarter 2017 on Friday, 17 November 2017.A presentation by BerGenBio’s senior management team will take place at 9.00 am CET at: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Meeting Room: Bjørvika The presentation will webcast live and the link will be available at www.bergenbio.com in the section Investors/Reports and presentations/Webcasts. A recording will be

Selvaag Bolig ASA: Simultaneous interpretation (English) of CMU presentation

A simultaneous interpretation in English of Selvaag Bolig's CMU presentation given in Norwegian 9 November at 09:45 CET is now published at www.selvaagboligasa.no. It can also be found here: http://webtv.hegnar.no/presentation.php?webcastId=72596187 Selvaag Bolig and its affiliates disclaim all liability for any inaccuracies, errors or omissions that may possibly occur in the simultaneous interpretation. Further information fromKristoffer Gregersen, vice president communications and marketing, Selvaag Bolig ASATelephone: +47 957 75 593, e-mail: kgr@selvaagbolig.no Selvaag

IAR Systems adds static and runtime analysis to functional safety tools for Renesas RX MCUs

Latest version integrates powerful code analysis and adds support for Renesas RXv2 coreUppsala, Sweden—November 10, 2017—IAR Systems®, the future-proof supplier of software tools and services for embedded development, launches a new version of the functional safety edition of the complete development toolchain IAR Embedded Workbench® for Renesas RX family of microcontrollers (MCUs). The new version integrates IAR Systems’ add-on tools C-STAT® and C-RUN® for powerful static and runtime analysis. In addition, support for the Renesas RXv2 CPU core is now available. Functional safety is one

Acclaimed international cast confirmed, as Lagardère Studios Distribution signs global distribution of crime thriller Arctic Circle

The series, to be filmed in Finnish Lapland, has completed its cast with new names. Lead roles will feature Iina Kuustonen, Pihla Viitala and acclaimed German actors Maximilian Brückner and Clemens Schick. The Finnish-German co-production will be directed by Hannu Salonen.The Finnish-German co-production will start shooting in a studio in Helsinki at the end of November. The production will continue filming on location in Lapland during winter 2018. The series is co-produced by Yellow Film & TV , the largest independent

ABB appoints Jessica Mitchell as Head of Investor Relations

Zurich, Switzerland, November 10, 2017ABB announced today that Jessica Mitchell has been appointed Head of Investor Relations effective November 15, 2017, reporting to the company’s Chief Financial Officer, Timo J. Ihamuotila. She succeeds Alanna Abrahamson, who has been appointed CFO of ABB’s Industrial Automation division. Abrahamson will assume her new role as of March 1, 2018, after a smooth transition in Investor Relations. Mitchell joins ABB from BP, where she had been Head of Group Investor Relations since August 2011. She has more than 20 years’ experience in the oil and gas

There are no items matching the current filter
There are no more items matching the current filter
Back to top